Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
12.1M
-
Shares change
-
+54.6K
-
Total reported value, excl. options
-
$141M
-
Value change
-
-$5.57M
-
Number of buys
-
53
-
Number of sells
-
-34
-
Price
-
$11.69
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q3 2015
102 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q3 2015.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.1M shares
of 50.5M outstanding shares and own 23.96% of the company stock.
Largest 10 shareholders include FMR LLC (2.16M shares), BlackRock Fund Advisors (1.48M shares), Broadfin Capital, LLC (1.28M shares), VANGUARD GROUP INC (1.17M shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (522K shares), STATE STREET CORP (480K shares), BlackRock Institutional Trust Company, N.A. (445K shares), JPMORGAN CHASE & CO (428K shares), TFS CAPITAL LLC (383K shares), and NORTHERN TRUST CORP (338K shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.